Vaccination of immunosuppressed patients
Tidsskr Nor Laegeforen. 2026 Apr 9;146(5).
doi: 10.4045/tidsskr.25.0555.
Print 2026 Apr 21.
[Article in
English,
Norwegian]
Authors
Marton König
1
, Trygve Holmøy
2
, Gro Owren Nygaard
1
, Jon Riise
3
, Karsten Midtvedt
4
, Guro Løvik Goll
5
, Kristin Kaasen Jørgensen
6
, Ludvig A Munthe
7
, Børre Fevang
8
, Anders Eivind Myhre
9
, Marius Trøseid
8
Affiliations
- 1 Nevrologisk avdeling, Oslo universitetssykehus, og, Universitetet i Oslo.
- 2 Nevrologisk avdeling, Akershus universitetssykehus, og, Universitetet i Oslo.
- 3 Avdeling for kreftbehandling, Oslo universitetssykehus.
- 4 Avdeling for transplantasjonsmedisin, Oslo universitetssykehus.
- 5 Revmatologisk avdeling, Diakonhjemmet sykehus, og, Universitetet i Oslo.
- 6 Gastromedisinsk avdeling, Akershus universitetssykehus, og, Universitetet i Oslo.
- 7 Avdeling for immunologi, Oslo universitetssykehus, og, Universitetet i Oslo.
- 8 Seksjon for klinisk immunologi og infeksjonssykdommer, Oslo universitetssykehus, og, Universitetet i Oslo.
- 9 Avdeling for blodsykdommer, Oslo universitetssykehus.
Abstract
Chronically ill patients with a weak immune system are at increased risk of severe infections, often as a result of immunomodulatory therapy rather than the underlying disease. Many patients in this group exhibit reduced vaccine responses and require tailored vaccination regimens. Following the launch of the national Adult Immunisation Programme, all doctors must stay abreast of current guidance on vaccination in immunosuppressed patients. This clinical review article summarises interdisciplinary knowledge on patients with a reduced vaccine response.
MeSH terms
-
Humans
-
Immunocompromised Host* / immunology
-
Immunosuppressive Agents / adverse effects
-
Practice Guidelines as Topic
-
Vaccination*
-
Vaccines* / administration & dosage
-
Vaccines* / immunology
Substances
-
Vaccines
-
Immunosuppressive Agents